NASDAQ:ETNB 89bio (ETNB) News Today $15.44 0.00 (0.00%) (As of 09/29/2023 ET) Add Compare Share Share Today's Range$14.73▼$15.6050-Day Range$15.07▼$17.7852-Week Range$5.24▼$22.93Volume2.46 million shsAverage Volume1.52 million shsMarket Capitalization$1.17 billionP/E RatioN/ADividend YieldN/APrice Target$37.44 HeadlinesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadline8,800 Shares in 89bio, Inc. (NASDAQ:ETNB) Acquired by Denali Advisors LLCmarketbeat.com - September 29 at 6:43 AM89bio (NASDAQ:ETNB) Stock Rating Reaffirmed by Royal Bank of Canadaamericanbankingnews.com - September 24 at 3:08 AMRBC Capital Reiterates 89bio (ETNB) Outperform Recommendationnasdaq.com - September 23 at 8:01 AMThe Latest Analyst Ratings for 89biomarkets.businessinsider.com - September 22 at 4:59 PMRBC Capital Remains a Buy on 89bio (ETNB)markets.businessinsider.com - September 22 at 11:59 AM89bio Gets FDA Breakthrough Designation for Pegozafermin in NASH >ETNBmarketwatch.com - September 21 at 12:24 PMH.C. Wainwright Sticks to Their Buy Rating for 89bio (ETNB)markets.businessinsider.com - September 21 at 12:24 PM89bio Announces U.S. FDA has Granted Breakthrough Therapy Designation for Pegozafermin in Nonalcoholic Steatohepatitis (NASH)finance.yahoo.com - September 21 at 12:24 PM89bio to Participate in the 2023 Cantor Global Healthcare Conferencefinance.yahoo.com - September 20 at 12:20 PMGreat Point Partners LLC Acquires Shares of 250,000 89bio, Inc. (NASDAQ:ETNB)marketbeat.com - September 12 at 10:12 AM89bio Insider Ups Holding By 41% During Yearfinance.yahoo.com - September 9 at 2:47 PM89bio to Participate in the H.C. Wainwright 25th Annual Global Investment Conferencefinance.yahoo.com - September 5 at 11:22 AMExodusPoint Capital Management LP Makes New Investment in 89bio, Inc. (NASDAQ:ETNB)marketbeat.com - August 30 at 6:31 AM89bio earns ‘Buy’ rating in initial coverage on positive prospects for NASH therapeuticproactiveinvestors.com - August 28 at 4:42 PME Fund Management Co. Ltd. Buys New Shares in 89bio, Inc. (NASDAQ:ETNB)marketbeat.com - August 23 at 8:55 AM89bio, Inc. (NASDAQ:ETNB) Forecasted to Post Q3 2023 Earnings of ($0.46) Per Sharemarketbeat.com - August 14 at 2:31 AMCantor Fitzgerald Maintains 89bio (ETNB) Overweight Recommendationmsn.com - August 11 at 10:47 PMRBC Capital Maintains 89bio (ETNB) Outperform Recommendationmsn.com - August 11 at 12:28 AMHC Wainwright & Co. Reiterates 89bio (ETNB) Buy Recommendationmsn.com - August 11 at 12:28 AM89bio, Inc.: A Big Bet On NASHseekingalpha.com - August 10 at 1:48 PMFederated Hermes Inc. Acquires New Stake in 89bio, Inc. (NASDAQ:ETNB)marketbeat.com - August 10 at 9:21 AM89bio, Inc.: 89bio Reports Second Quarter 2023 Financial Results and Provides Corporate Updatefinanznachrichten.de - August 10 at 8:16 AM89bio Reports Second Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - August 9 at 5:14 PM89bio, Inc. (NASDAQ:ETNB) Receives Average Rating of "Buy" from Analystsmarketbeat.com - July 26 at 8:45 AMVirtu Financial LLC Acquires New Holdings in 89bio, Inc. (NASDAQ:ETNB)marketbeat.com - July 21 at 7:37 AM20,000 Shares in 89bio, Inc. (NASDAQ:ETNB) Bought by DekaBank Deutsche Girozentralemarketbeat.com - July 19 at 4:46 AM89bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)finance.yahoo.com - July 12 at 5:19 PMRaymond James Financial Services Advisors Inc. Has $1.66 Million Holdings in 89bio, Inc. (NASDAQ:ETNB)marketbeat.com - July 12 at 4:15 AMAre Medical Stocks Lagging 89BIO (ETNB) This Year?finance.yahoo.com - July 7 at 11:36 AMAre Medical Stocks Lagging 89BIO (ETNB) This Year?finance.yahoo.com - July 7 at 11:36 AM89bio (ETNB) Price Target Increased by 6.60% to 38.19msn.com - July 6 at 10:27 PMBTIG Maintains 89bio (ETNB) Buy Recommendationmsn.com - July 3 at 1:34 PMBTIG Maintains Buy Rating for 89bio: Here's What You Need To Knowmarkets.businessinsider.com - July 3 at 1:34 PMWhat 6 Analyst Ratings Have To Say About 89biomarkets.businessinsider.com - July 3 at 8:34 AM89bio, Inc. (NASDAQ:ETNB) Receives Consensus Recommendation of "Buy" from Analystsmarketbeat.com - July 1 at 4:11 AM89bio Publishes Positive Results from Phase 2 ENTRIGUE Trial of Pegozafermin in Patients with Severe Hypertriglyceridemia (SHTG) in Nature Medicinefinance.yahoo.com - June 24 at 10:14 AMEvercore ISI Group Initiates Coverage of 89bio (ETNB) with Outperform Recommendationmsn.com - June 13 at 5:18 PM89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)finance.yahoo.com - June 7 at 6:32 PMSVB Securities Keeps Their Buy Rating on 89bio (ETNB)markets.businessinsider.com - June 7 at 8:31 AM89bio Announces Late-Breaker Oral Presentation of Data from the Phase 2 ENLIVEN Study of Pegozafermin at EASL International Liver Congress 2023finance.yahoo.com - June 7 at 8:31 AM89bio, Inc. (NASDAQ:ETNB) Receives Consensus Rating of "Buy" from Analystsmarketbeat.com - June 6 at 3:33 AM89bio (NASDAQ: ETNB)fool.com - June 4 at 8:05 PM89BIO (ETNB) Just Overtook the 20-Day Moving Averagefinance.yahoo.com - May 29 at 3:00 PMRaymond James Financial Services Advisors Inc. Sells 57,417 Shares of 89bio, Inc. (NASDAQ:ETNB)marketbeat.com - May 28 at 4:47 AM89bio: Great Prospects After Excellent Phase 2 Dataseekingalpha.com - May 28 at 4:18 AM89bio Initiates Phase 3 ENTRUST Trial of Pegozafermin in Patients with Severe Hypertriglyceridemia (SHTG)finance.yahoo.com - May 23 at 9:41 AM89bio (ETNB) Investor Presentation - Slideshowseekingalpha.com - May 18 at 12:21 PMSG Americas Securities LLC Acquires New Shares in 89bio, Inc. (NASDAQ:ETNB)marketbeat.com - May 15 at 4:21 AMInstitutional investors are 89bio, Inc.'s (NASDAQ:ETNB) biggest bettors and were rewarded after last week's US$90m market cap gainfinance.yahoo.com - May 13 at 9:38 AM89bio, Inc. (NASDAQ:ETNB) Given Consensus Rating of "Buy" by Brokeragesmarketbeat.com - May 12 at 3:18 AM Get 89bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ETNB and its competitors with MarketBeat's FREE daily newsletter. Email Address ETNB Media Mentions By Week ETNB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ETNB News Sentiment▼0.430.68▲Average Medical News Sentiment ETNB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ETNB Articles This Week▼52▲ETNB Articles Average Week Get 89bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ETNB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Amylyx Pharmaceuticals News Merus News Xencor News ANI Pharmaceuticals News OPKO Health News Biohaven News Kiniksa Pharmaceuticals News Aurinia Pharmaceuticals News Sage Therapeutics News Day One Biopharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:ETNB) was last updated on 9/30/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 89bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.